Role of exhaled nitric oxide in asthma

Immunology and Cell Biology

Volumn 79, Issue 2, 2001, Pages 178-190

  Yates, D H ^a  

^a NONE   (Australia)

Author keywords

Airway inflammation; Asthma; Nitric oxide; Nitrosothiols

Indexed keywords

AMINOGUANIDINE; ARGININE; CORTICOSTEROID; ENDOTHELIUM DERIVED RELAXING FACTOR; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROSO DERIVATIVE;

AIRWAY RESISTANCE; ARTICLE; ASTHMA; CYTOKINE RELEASE; DISEASE MARKER; EOSINOPHIL; EPITHELIUM CELL; INFLAMMATION; MACROPHAGE; OXIDATIVE STRESS;

ANIMALS; ASTHMA; HUMANS; NITRIC OXIDE;

ANIMALIA;

EID: 0035067092     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2001.00990.x     Document Type: Article

References (128)

1. NO news is good news
2. The L-arginine-nitric oxide pathway
3. Nitric oxide and lung disease
4. Endogenous nitric oxide is present in exhaled air of rabbits, guinea-pigs and humans
5. Increased nitric oxide in exhaled air of asthmatic patients
6. Regular inhaled budesonide decreases nitric oxide concentration in the exhaled air of asthmatic patients
7. Exhaled nitric oxide: A new lung function test
8. Exhaled and nasal nitric oxide measurement: Recommendations
9. Isoprostanes and other exhaled markers in respiratory disease
10. Nitroglycerine
11. Biological roles of nitric oxide
12. The origin of nitrate in the urine
13. Nitric oxide: Mediator, murderer, and medicine
14. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
15. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
16. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
17. The physiological role of nitric oxide
18. The arginine-nitric oxide pathway: A target for new drugs
19. Genotoxicity of nitric oxide
20. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors
21. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin
22. S-nitrosothiols: A class of nitric oxide drugs
23. Heme oxygenase 1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury
24. Nitric oxide as a secretory product of mammalian cells
25. Nitric oxide synthases: Roles, tolls and controls
26. Nitric oxide synthase activity in mitochondria
27. Nitric oxide synthase in human and rat lung: Immunocytochemical and histochemical localization
28. Expression of inducible nitric oxide synthase in human lung epithelial cells
29. Relaxation of bronchial smooth muscle by S-nitrosothiols in vitro
30. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways
31. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock
32. Glucocorticosteroids inhibit the expression of nitric oxide synthase in macrophages
33. Glucocorticoids inhibit the induction of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells
34. Nitric oxide (NO) can relax canine airway smooth muscle
35. Pharmacological differentiation of epithelium derived relaxing factor from nitric oxide
36. Bronchodilator action of inhaled nitric oxide in guinea pigs
37. Is nitric oxide inhalation beneficial to the asthmatic patient?
38. Endothelial modulation of pulmonary vascular tone
39. Nitric oxide and hypoxic pulmonary hypertension
40. G-nitro-L-arginine in rabbit intrapulmonary arteries
41. Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury
42. Inhaled nitric oxide selectively reverses hypoxic pulmonary vasoconstriction without causing systemic hypertension
43. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
44. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension
45. A therapeutic role for chronic inhaled nitric oxide?
46. Nitric oxide and hypoxic pulmonary hypertension
47. Nitrenergic transmission: Nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission
48. Effect of an inhibitor of nitric oxide synthase on neural transmission in human bronchi
49. Electrical field stimulation causes endothelium-dependent and nitric oxide mediated relaxation of pulmonary artery
50. Regulation of pulmonary vascular tone
51. Nitric oxide synthase in human and rat lung: Immunocytochemical and histochemical localization
52. Exhaled nitric oxide as a marker in asthma
53. Constitutive and inducible nitric oxide synthase gene expression, regulation and activity in human lung epithelial cells
54. Induction of nitric oxide synthase in asthma
55. Nitric oxide in adult lung disease
56. Primarily nasal origin of exhaled nitric oxide and its absence in Kartagener's syndrome
57. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide
58. Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression
59. Rapid induction of mRNA for NOS II in rat alveolar macrophages by intratracheal instillaton of Mycobacterium tuberculosis and Mycobacterium avium
60. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages
61. L-arginine is required post expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells
62. Regulation of antigen-presenting cell function(s) in the lung and airway tissues
63. Nitric oxide and asthmatic inflammation
64. Inhibition of eosinophil chemotaxis by chronic blockade of nitric oxide synthase
65. NO modulates eosinophil infiltration in antigen-induced airway inflammation in rats
66. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro
67. The effect of endogenous NO on neurogenic plasma exudation in guinea pig airways
68. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure
69. Single-breath nitric oxide measurements in asthmatic patients and smokers
70. Exhaled nitric oxide measurements in normal and asthmatic children
71. Expired nitric oxide as a marker for childhood asthma
72. Measurements of nitric oxide using the single-breath technique with positive expiratory pressure in infants
73. Measurement of exhaled nitric oxide in the elderly
74. Endogenous nitric oxide in the airways of different animal species
75. The elevated level of nitric oxide in asthmatic patients is mainly derived from the lower respiratory tract
76. Auto-inhalation of nitric oxide after endogenous synthesis in nasopharynx
77. Exhaled nitric oxide in a population sample of young adults
78. Measurement of exhaled nitric oxide by three different techniques
79. Nasal nitric oxide in man
80. Exhaled nitric oxide in isolated pig lungs
81. Air contamination with nitric oxide: Effect on exhaled nitric oxide response
82. Methodological aspects of exhaled nitric oxide measurements
83. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide
84. Circadian variation in exhaled nitric oxide in nocturnal asthma
85. Endogenous nitric oxide in expired air: Effects of acute exercise in humans
86. Repeated FVC manoeuvres reduce expired nitric oxide in healthy individuals
87. 2-agonists on exhaled nitric oxide (NO) in asthmatic patients
88. The effect of bronchodilators on exhaled nitric oxide (NO) in patients with bronchial asthma
89. The effect of alcohol on exhaled nitric oxide
90. The effect of caffeine upon exhaled nitric oxide levels
91. Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects
92. Acute and chronic effects of cigarette smoking on exhaled nitric oxide
93. Passive smoke inhalation decreases exhaled nitric oxide in normal subjects
94. Exhaled nitric oxide in chronic obstructive pulmonary disease
95. Role of endogenous nitric oxide in airflow obstruction in smokers
96. Nitric oxide measured with single breath and tidal-breathing methods in asthma and COPD
97. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma
98. Elevated levels of exhaled nitric oxide in bronchiectasis
99. Exhaled nitric oxide and broncholalveolar lavage nitrite/nitrate in active pulmonary sarcoidosis
100. Decreased nitric oxide in the exhaled air of systemic sclerosis patients with pulmonary hypertension
101. Relationship between exhaled nitric oxide and and childhood asthma
102. Expired nitric oxide levels during treatment of acute asthma
103. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide
104. Nitric oxide measurements in exhaled air after bronchial challenge with house dust mite
105. Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children
106. Increased nitric oxide in exhaled air of normal subjects with upper respiratory tract infections
107. Influenza vaccine: Changes in exhaled nitric oxide and airway inflammatory cells
108. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects
109. Effect of a nitric oxide synthase inhibitor and a glucorticosteroid on exhaled nitric oxide
110. Lack of inhibitory effect of dexamethasone on exhalation of nitric oxide by healthy humans
111. Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma
112. Reduction in exhaled nitric oxide after a single dose of nebulised budesonide in patients with asthma
113. Effect of inhaled budesonide on lung function and airway inflammation: Assessment by various inflammatory markers in mild asthma
114. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma
115. Increase in exhaled nitric oxide and correlation with symptoms and disease severity despite treatment with oral and inhaled glucocorticosteroids
116. Exhaled nitric oxide is decreased after inhalation of a specific inhibitor of inducible nitric oxide synthase in asthmatic but not in normal subjects
117. Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide
118. Effect of nitric oxide inhibition on bronchial tone and methacholine-induced bronchoconstriction in man
119. Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5′-monophosphate in asthma
120. Effect of allergen challenge on epithelial nitrotyrosine immunostaining in bronchial biopsies of atopic asthmatics
121. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: Effect of inhaled glucocorticoid
122. Effects of reactive oxygen and nitrogen metabolites on eotaxin-induced eosinophil chemotactic activity in vitro
123. NO waiting to exhale in asthma
124. Cross sectional study of exhaled nitric oxide levels following lung transplantation
125. Endogenous airway acidification: Implications for asthma pathophysiology
126. The clinical control of asthma after adding airway hyperresponsiveness (AHR) to the guidelines for long-term therapy
127. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma
128. Isoprostanes and other exhaled markers in respiratory diseases